StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant (VRX) PT Cut to $53 at Jefferies
March 16, 2016 11:05 AM
Jefferies analyst David Steinberg lowered his price target on Valeant Pharmaceuticals (NYSE: VRX) to $53.00 (from $106.00) but maintained his ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Valeant Pharma (VRX) Price Target Lowered to $45 at TD Securities
March 16, 2016 11:16 AM
Valeant (VRX) PT Cut to $40 at Canaccord Genuity
March 16, 2016 9:40 AM
Valeant (VRX) Default 'Unlikely', Says Rodman & Renshaw
March 16, 2016 7:43 AM
Nomura Securities Downgrades Valeant Pharmaceuticals (VRX) to Neutral
March 16, 2016 6:55 AM
CIBC Downgrades Valeant Pharmaceuticals (VRX) to Sector Underperform
March 15, 2016 5:38 PM
